Supercharge new treatment development.
We map the complete landscape of KOLs, DOLs, and PAGs across every therapeutic area, then accelerate clinical trial enrollment through targeted digital recruitment.
We map the complete landscape of KOLs, DOLs, and PAGs across every therapeutic area, then accelerate clinical trial enrollment through targeted digital recruitment.
Our platform
Adnexi is a technology platform built to accelerate biopharma treatment development and launch. We map the experts and influence networks shaping your therapeutic area, then take a proactive approach to recruiting eligible patients directly into your clinical trials. One platform, from landscape intelligence to enrolled patient.
Our platform maps every KOL, DOL, and advocacy group across therapeutic areas, giving your team a complete, daily-updated picture of who matters and why.
From digital ad to enrolled patient, our recruitment engine handles the full pipeline: prescreener, site matching, bot detection, and real-time tracking.
We identify the most influential healthcare professionals through peer nomination surveys, then visualize their networks and standing so your team knows exactly who leads your therapeutic area.
Every day saved between molecule and market is a day given back to a patient who is waiting for the most innovative treatments. Adnexi compresses the path: faster expert engagement, faster patient enrollment, faster patient finding for serious diseases, including oncology and rare diseases.
A continuously-refreshed, customized platform of KOLs, DOLs and patient advocacy organizations to drive your engagement strategy. Stop relying on stale and incomplete lists. Our platform has all of the data and up to date.
Every KOL, DOL and PAG identified and profiled fully with massive data aggregation for impact.
Sub-indication coverage down to protocol-relevant patient populations, such as ER+ HER2-low metastatic breast cancer.
New publications, presentations and digital activity flow into profiles every 24 hours, so teams are not working from last quarter’s spreadsheet.
Patient organizations linked to the experts they trust and the trials they amplify, with reach and engagement metrics.
Composite scoring across scientific output, clinical leadership and patient-facing influence, weighted to your therapeutic area.
Pipe records straight into your CRM, MSL platform, or congress planning tools.
An end-to-end recruitment engine that owns the full pipeline: targeted media, prescreeners, bot detection, site matching, and live enrollment dashboards. Recruitment performance is tracked in one place, from first outreach through site referral and enrollment.
Audiences built from indication signal by condition, geo, language and more.
Branching logic configured per protocol I/E criteria, with abandonment-aware question ordering to maximize completion.
Multi-layer device, behavior and answer-pattern checks.
Live capacity, geographic proximity and patient preference factored into every referral. Routed in seconds, not days.
Funnel, cost-per-result, channel mix and site-by-site performance, updated continuously, not in monthly PDFs.
Built to local regulations wherever we operate, including GDPR, CCPA and more. All patient-facing content is IRB approved. PII stays walled from sponsor view, with an auditable handoff to clinical trial sites.
We run structured peer-nomination surveys with verified specialists, then visualize the resulting graph so you can see who actually leads thinking in your therapeutic area, and who they listen to.
We field rounds with verified specialists in your indication and ask the question that matters: who do you turn to for clinical guidance? Responses are anonymized, weighted and triangulated.
The resulting graph surfaces the experts who actually structure the field, rather than the accounts with the largest follower counts. Eigenvector centrality, betweenness and bridging metrics tell you who connects which sub-communities.
See at a glance who drives guidelines, who shapes patient sentiment, and the rare voices who do both. Critical for medical affairs, advisory board planning, and launch readiness.
Networks shift around guideline updates, congress cycles and competitor entries. We re-field nominations on a cadence aligned to your launch readiness plan.
Case studies
Real results from our work with biopharma and medical device companies.
Adnexi identified and engaged patient advocacy groups and digital opinion leaders to drive trial awareness in a rare oncology indication.
Read case studyAdnexi's proprietary platform accelerated clinical trial enrollment through targeted digital screening and site matching for an ultra rare disease program.
Read case studyThe Adnexi platform powered a patient lead generation program to accelerate trial enrollment for a Phase 2 study in neurodegenerative disease.
Read case study